CCR5 Chemokine Receptors: Gatekeepers of HIV-1 Infection

Publisher： Bentham Science Publishers

E-ISSN： 1875-5852|2|3|265-278

ISSN： 1568-0053

Source： Current Drug Targets - Infectious Disorders, Vol.2, Iss.3, 2002-09, pp. : 265-278

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting of Th1-Associated Chemokine Receptors CXCR3 and CCR5 as Therapeutic Strategy for Inflammatory Diseases

By  

Mini Reviews in Medicinal Chemistry, Vol. 7, Iss. 11, 2007-11 ,pp. : 1089-1096

Bentham Science Publishers

Access to resources Recommend Favorite

Treatment of HIV infection with the CCR5 antagonist maraviroc

By Kromdijk Wiete   Huitema Alwin DR   Mulder Jan Willem  

Expert Opinion on Pharmacotherapy, Vol. 11, Iss. 7, 2010-05 ,pp. : 1215-1223

Informa Healthcare

Access to resources Recommend Favorite

Genetic Polymorphisms in the Chemokine and Chemokine Receptors: Impact on Clinical Course and Therapy of the Human Immunodeficiency Virus Type 1 Infection (HIV-1)

By  

Current Medicinal Chemistry, Vol. 14, Iss. 12, 2007-05 ,pp. : 1325-1334

Bentham Science Publishers

Access to resources Recommend Favorite

HIV-1 infection and CCR5∆32 homozygosis

By Ballana Ester   Esté José A  

Future Virology, Vol. 7, Iss. 7, 2012-07 ,pp. : 653-658

Future Medicine

Access to resources Recommend Favorite

Recent Progress in the Discovery of New CCR5 and CXCR4 Chemokine Receptor Antagonists as Inhibitors of HIV-1 Entry. Part 2*

By  

Current Medicinal Chemistry - Anti-Infective Agents, Vol. 4, Iss. 2, 2005-04 ,pp. : 133-152

Bentham Science Publishers

Access to resources Recommend Favorite